These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2985785)

  • 1. Orally active and potent inhibitors of gamma-aminobutyric acid uptake.
    Ali FE; Bondinell WE; Dandridge PA; Frazee JS; Garvey E; Girard GR; Kaiser C; Ku TW; Lafferty JJ; Moonsammy GI
    J Med Chem; 1985 May; 28(5):653-60. PubMed ID: 2985785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates.
    Andersen KE; Sørensen JL; Huusfeldt PO; Knutsen LJ; Lau J; Lundt BF; Petersen H; Suzdak PD; Swedberg MD
    J Med Chem; 1999 Oct; 42(21):4281-91. PubMed ID: 10543872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of 2-azaspiro[4.5]decane-6-carboxylates as GABA-uptake inhibitors.
    Fleischhacker W; Lauritz S; Urban E; Baumann P; Bittiger H
    Arch Pharm (Weinheim); 1996 Mar; 329(3):149-54. PubMed ID: 9005814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperidinyl-3-phosphinic acids as novel uptake inhibitors of the neurotransmitter gamma-aminobutyric acid (GABA).
    Kehler J; Stensbøl TB; Krogsgaard-Larsen P
    Bioorg Med Chem Lett; 1999 Mar; 9(6):811-4. PubMed ID: 10206541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel gamma-aminobutyric acid (GABA) uptake inhibitors. 5.(1) Preparation and structure-activity studies of tricyclic analogues of known GABA uptake inhibitors.
    Andersen KE; Sørensen JL; Lau J; Lundt BF; Petersen H; Huusfeldt PO; Suzdak PD; Swedberg MD
    J Med Chem; 2001 Jun; 44(13):2152-63. PubMed ID: 11405652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxy- and amino-substituted piperidinecarboxylic acids as gamma-aminobutyric acid agonists and uptake inhibitors.
    Jacobsen P; Labouta IM; Schaumburg K; Falch E; Krogsgaard-Larsen P
    J Med Chem; 1982 Oct; 25(10):1157-62. PubMed ID: 6292417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gamma-aminobutyric acid release from synaptosomes by local anesthetics.
    Ikeda M; Dohi T; Tsujimoto A
    Anesthesiology; 1983 Jun; 58(6):495-9. PubMed ID: 6859579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives.
    Andersen KE; Lau J; Lundt BF; Petersen H; Huusfeldt PO; Suzdak PD; Swedberg MD
    Bioorg Med Chem; 2001 Nov; 9(11):2773-85. PubMed ID: 11597457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of carriers for dopamine and GABA uptake on a same nerve terminal in the rat brain.
    Bonanno G; Raiteri M
    Br J Pharmacol; 1987 May; 91(1):237-43. PubMed ID: 3594080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of the GABA uptake systems.
    Krogsgaard-Larsen P
    Mol Cell Biochem; 1980 Jun; 31(2):105-21. PubMed ID: 6251361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fenfluramine administration on synaptosomal uptake of some neurotransmitters and on synaptosomal enzymes which metabolise GABA.
    Kouyoumdjiian JC; Gonnard P; Belin MF
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Oct; 309(1):7-11. PubMed ID: 42851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate.
    Andersen KE; Braestrup C; Grønwald FC; Jørgensen AS; Nielsen EB; Sonnewald U; Sørensen PO; Suzdak PD; Knutsen LJ
    J Med Chem; 1993 Jun; 36(12):1716-25. PubMed ID: 8510100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice.
    Yunger LM; Fowler PJ; Zarevics P; Setler PE
    J Pharmacol Exp Ther; 1984 Jan; 228(1):109-15. PubMed ID: 6694095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA agonists and uptake inhibitors. Synthesis, absolute stereochemistry, and enantioselectivity of (R)-(-)- and (S)-(+)-homo-beta-proline.
    Nielsen L; Brehm L; Krogsgaard-Larsen P
    J Med Chem; 1990 Jan; 33(1):71-7. PubMed ID: 2153214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I).
    Zheng J; Wen R; Luo X; Lin G; Zhang J; Xu L; Guo L; Jiang H
    Bioorg Med Chem Lett; 2006 Jan; 16(1):225-7. PubMed ID: 16246548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diisopropylfluorophosphate and GABA synaptic function: effect on levels, enzymes, release and uptake in the rat striatum.
    Sivam SP; Nabeshima T; Lim DK; Hoskins B; Ho IK
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):51-60. PubMed ID: 6316437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by neuroleptics of uptake of 3H-GABA into rat brain synaptosomes.
    Fjalland B
    Acta Pharmacol Toxicol (Copenh); 1978 Jan; 42(1):73-6. PubMed ID: 579714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gamma-Vinyl GABA: effects of chronic administration on the metabolism of GABA and other amino compounds in rat brain.
    Perry TL; Kish SJ; Hansen S
    J Neurochem; 1979 Jun; 32(6):1641-5. PubMed ID: 448357
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid.
    Löscher W; Hönack D; Gramer M
    J Neurochem; 1989 Dec; 53(6):1737-50. PubMed ID: 2809589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
    White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.